Additionally, long-term DHA treatment had beneficial effects on liver health, including lower alanine aminotransferase (ALT) levels, reduced liver weight, and decreased hepatic triglyceride content [18], suggesting a delay in MASLD progression in 18-month-old obese female mice (Table S1). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.